Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $1.48, $0.10 better than the analyst estimate of $1.38. Revenue for the quarter came in at $692.3 million versus the consensus estimate of $686.37 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.